Bodal Chemicals Limited herewith submit Consolidated and Standalone Audited financial Results for quarter and year ended 31st March 2026
BODALCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 11.9 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Bodal Chemicals reported consolidated revenue of Rs 20,122.42 million for FY2026, up 15.1% from Rs 17,484.29 million in FY2025. Net profit after tax grew 111% to Rs 320.60 million from Rs 151.89 million. The company recognized Rs 269.80 million as SGST incentive income under the Punjab Industrial Incentive Scheme, including amounts from earlier periods. The board also approved the sale of Unit I at Vatva, Ahmedabad, which has been inoperative since long. Assets held for sale include land at Unit XII (Rs 191.99 million) and Unit I assets (Rs 62.96 million). The auditors issued an unmodified opinion with an emphasis of matter regarding the SGST incentive income recognition. The company also recorded Rs 69.87 million loss from hyperinflationary accounting for its Turkey subsidiaries.
Strong profit growth of 111% with revenue up 15% is positive, but the large SGST incentive income (Rs 269.80 million) significantly boosted bottom-line and investors should monitor if this is one-time in nature. The sale of non-core inoperative units shows ongoing asset rationalisation.